Darunavir/Ritonavir
Optimized Antiretroviral Therapy with Darunavir/Ritonavir, Etravirine and/or Raltegarvir: A Salvage Therapy Option in HIV 1 Infected Patients with Long Term Therapeutic Failures, about 23 Cases
... Objectives: The aims of this study was to analyze the immuno-virologic response after optimised background antiret- roviral therapy (OBT) associated to new active antiretroviral treatment (ART) in HIV-1 infected patients ...
6
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
... of ritonavir, protease inhibitors impose a high gen- etic barrier against the selection of drug-resistant variants of HIV and are therefore especially reliable options for patients for whom poor antiretroviral ...
10
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
... (RAL)+backbone, darunavir (DRV)+ritonavir(r)+backbone and efavirenz/tenofovir/emtricitabine (EFV/TDF/FTC) in HIV- positive treatment-naïve patients and compared with RAL+backbone in treatment-experienced ...
11
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
... Abstract: Current antiretroviral (ARV) therapy for the treatment of human immunodeficiency virus (HIV-1)-infected patients provides long-term control of viral load (VL). Darunavir (DRV) is a nonpeptidomimetic ...
15
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
... The present work is the 48-week update of a previously reported study [1], concerning a retrospective-prospective follow-up of subjects who had been switched for any reason to a dual combination of dolutegravir (DTG) ...
7
Stability indicating RP-HPLC method for simultaneous estimation of darunavir and ritonavir in pure drug and tablet dosage form
... combination, ritonavir and darunavir in bulk and tablet form. Ritonavir and darunavir are extracted with mobile phase from the ...for ritonavir and darunavir, ...for ...
13
STABILITY INDICATING REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR THE SIMULTANEOUS ESTIMATION OF DARUNAVIR AND RITONAVIR
... To 5 ml of working standard containing DRV and RTV, 2.5 ml of 0.1N NaOH was added and refluxed at 60°C for 30 minutes and neutralized with 0.1N HCl. The resultant solutions were injected into system and chromatograms ...
6
STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF RITONAVIR AND DARUNAVIR IN BULK AND ITS SYNTHETIC MIXTURE
... bath then filtered through 0.45µ filter under vacuum filtration before analysis. Mobile phase was delivered at 1.0 ml per min. Method Development and Validation: Wavelength selection: The UV spectrum of diluted solutions ...
12
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir
... with darunavir? Both are dosed with ritonavir, and both are administered twice ...while darunavir is only supplied as ...for darunavir/ ritonavir, with 2 tablets twice daily, vs 4 ...
21
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
... Abbreviations: ABC/3TC, abacavir/lamivudine; DRv/RTv, darunavir/ritonavir; DTG, dolutegravir; eFv, efavirenz; evG, elvitegravir; FTC, emtricitabine; INSTIs, integrase strand transfer i[r] ...
14
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)
... Secondary objectives were to establish: a) proportion of patients with RNA HIV-1 < 50 copies/mL at week 24 of treatment; b) stratification of all viral load determina- tions obtained during exposure to the DT; c) ...
9
Profile of etravirine for the treatment of HIV infection
... The global etravirine early access program (TMC125-C214) involved triple-class antiretroviral experienced patients who had received at least two prior PI-containing regimens. At screening, patients with undetectable ...
10
PHARMACOLOGICAL AND PHARMACEUTICAL PROFILE OF DARUNAVIR: A REVIEW
... Hypersensitivity to darunavir or to any of the excipients: Darunavir and ritonavir both are inhibitors of the CYP3A isoform. PREZISTA/ritonavir should not be co-administered with medicinal ...
8
Role of darunavir in the management of HIV infection
... DRV/r was further evaluated in 595 PI-experienced patients who were naïve to LPV/r and were randomized to receive DRV/r or LPV/r as part of the TITAN trial (TMC114/ritonavir In Treatment-experienced pAtients Naïve ...
9
Molecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor Darunavir
... ritonavir (46), D30N and N88D for nelfinavir (39), and I47A for lopinavir (14). Other mutations, such as I84V, lead to some level of resistance against almost all known PIs. These “pri- mary” mutations often ...
9
Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
... rived amplicons encompassing approximately 200 nucleotides of 3 ⬘ Gag (begin- ning at the unique ApaI restriction site), the entire protease, and the first 72 nucleotides of reverse transcriptase (RT) using the ...
11
Development of a Novel Method for Determination of 11 Antiretroviral Drugs Concentrations in Human Plasma by Ultra-Performance Liquid Chromatography- Photodiode Array Detection Method
... This method demonstrated a good separation result for 11 ARVs in 16 minutes as shown with PDA spectrum in Fig 1. The capacity factor (kʹ) was in the range of 1.832-34.628 and the resolution factor was in the range of ...
9
RP HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF LOPINAVIR AND RITONAVIR IN COMBINED TABLET DOSAGEFORM AND IN SPIKED HUMAN PLASMA
... and Ritonavir (RTV) [10-Hydroxy-2- methyl-5-(1-methylethyl)-1-[2-(1-methyl ethyl)-4- thiazolyl] -3,6-dioxo -8,11-bis (phenyl methyl)- 2,4,7,12-tetraaza tridecan-13-oic acid, 5-thiazolyl methyl ester, ...
12
RP-HPLC Method Development and Validation for the Simultaneous Estimation of Darunavir and Cobicistat in Bulk and Tablet Dosage Form
... claim Darunavir 800mg and Cobicistat 150mg was used to perform assay and the Average % of drug was found to be ...for Darunavir and Cobicistat respectively the results were shown in (Table-7) and the ...
10
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
... Recently, the emergence of second-generation DAAs changed the paradigm of hepatitis C treatment with SVR rates exceeding 90%, and regardless of the presence of cir- rhosis, former non-response [7, 8]. In contrast to ...
10